Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-30 @ 1:37 PM
Study NCT ID:
NCT04677933
Status:
COMPLETED
Last Update Posted:
2020-12-24
First Post:
2020-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002
Sponsor:
OliPass Australia Pty Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-17
First Submit QC Date:
None
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-23
Last Update Post Date:
2020-12-24
Last Update Post Date Type:
ACTUAL